Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • 475 Fc-silent anti-TIGIT antib...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
475 Fc-silent anti-TIGIT antibodies potentiate anti-tumor immunity without depleting regulatory T cells

475 Fc-silent anti-TIGIT antibodies potentiate anti-tumor immunity without depleting regulatory T cells

Bibliographic Details
Main Authors: Paul Foster, Amita Patnaik, Lisa Seitz, Dana Piovesan, Soonweng Cho, Xiaoning Zhao, Amy E Anderson, Nigel Walker, Hema Singh, Casey G Mitchell, Matthew J Walters, Kelsey E Sivick Gauthier, Amber E de Groot, Rebecca D Ray, Nina K Serwas
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Nonfucosylation of an anti-TIGIT antibody enhances FcγR engagement, driving innate immune activation and antitumor activity
    by: Alyson J. Smith, et al.
    Published: (2023-11-01)
  • 479 Fc-competent fully human anti-TIGIT blocking monoclonal antibodies demonstrated potent anti-tumor efficacy in preclinical models
    by: Xin Zhang, et al.
    Published: (2023-11-01)
  • Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation
    by: Jin-Hwan Han, et al.
    Published: (2020-10-01)
  • 253 Anti-TIGIT antibodies require enhanced FcγR co-engagement for optimal T and NK cell-dependent anti-tumor immunity
    by: Rebecca Ward, et al.
    Published: (2020-11-01)
  • Fc-competent multispecific PDL-1/TIGIT/LAG-3 antibodies potentiate superior anti-tumor T cell response
    by: Riyao Yang, et al.
    Published: (2023-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs